National Rosacea Society Launches New Seal of Acceptance Program

The National Rosacea Society (NRS) has announced that it is launching a Seal of Acceptance program to identify skin care and cosmetic products that may be suitable for people who suffer from rosacea. Companies interested in pursuing the Seal, to be displayed on accepted product packaging, may learn more and request an application online at or by contacting the Society at [email protected]. “One of the most common requests the Society receives from rosacea patients is for information about which skin care and cosmetic products are appropriate to use,” said Andrew Huff, president and executive director of the NRS. “We are excited to offer this new way to provide guidance to rosacea sufferers by recognizing products that have been shown to be unlikely to cause a flare-up.” 

Sensitive and easily irritated skin is a common issue for people with rosacea, a chronic disorder affecting an estimated 16 million Americans and 415 million people worldwide. In NRS surveys, 92 percent of rosacea sufferers reported burning, stinging or itching skin; 66 percent named certain skin care or cosmetic products as triggers for rosacea signs and symptoms; and 84 percent were “very interested” in more guidance on skincare.

The Seal of Acceptance program was developed under the guidance of Zoe Diana Draelos, M.D., FAAD, a clinical and research dermatologist and president of Dermatology Consulting Services, PLLC, who is a well-known authority on skin care and serves on the NRS board of directors. To be considered for the Seal, skin care and cosmetic products must be free of ingredients that cause skin barrier dysfunction, vasomotor instability (flushing) or unwanted neurosensory stimulation, such as burning or itching. Applicants must provide a full list of ingredients as well as human repeat insult patch test (HRIPT) data on at least 30 people and safety-in-use test data on at least 30 rosacea patients. 

Applications are anonymously reviewed by an independent panel of dermatologists. If approved, the Seal may be licensed for display on product packaging and marketing materials, and will be listed in a directory of accepted products to debut when the program launches to the public later in 2023.